25 May 2013
Keywords: BioMerieux, Knome, In vitro diagnostics, First-quarter 2010
Article | 22 April 2010
France’s bioMerieux and USA-based Knome have entered into a strategic agreement to collaborate in the development of next-generation, sequence-based ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 April 2010
24 May 2013
© 2013 thepharmaletter.com